Cargando…

Drug Treatment of Cluster Headache

Cluster headache belongs to the group of trigeminal autonomic headaches. This review summarizes drug therapy of cluster attacks and prophylactic treatment. Neurostimulation methods are not addressed. The therapy for acute cluster attacks includes inhalation of 100% oxygen, subcutaneous administratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans Christoph, May, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748342/
https://www.ncbi.nlm.nih.gov/pubmed/34919214
http://dx.doi.org/10.1007/s40265-021-01658-z
_version_ 1784631000026841088
author Diener, Hans Christoph
May, Arne
author_facet Diener, Hans Christoph
May, Arne
author_sort Diener, Hans Christoph
collection PubMed
description Cluster headache belongs to the group of trigeminal autonomic headaches. This review summarizes drug therapy of cluster attacks and prophylactic treatment. Neurostimulation methods are not addressed. The therapy for acute cluster attacks includes inhalation of 100% oxygen, subcutaneous administration of sumatriptan, and intranasal application of sumatriptan or zolmitriptan. Bridging therapy, which is used until oral prophylactic therapy is effective, is performed either with oral prednisolone or with a pharmacological block of the major occipital nerves. Best documented drugs for preventive treatment of cluster headache are verapamil and lithium, and possibly effective drugs are gabapentin, topiramate, divalproex sodium, and melatonin. The efficacy of monoclonal antibodies to the calcitonin gene-related peptide so far has been only demonstrated for episodic cluster headache. Several drug therapies are being investigated including ketamine, onabotulinumtoxinA, lysergic acid, and sodium oxybate.
format Online
Article
Text
id pubmed-8748342
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87483422022-01-20 Drug Treatment of Cluster Headache Diener, Hans Christoph May, Arne Drugs Review Article Cluster headache belongs to the group of trigeminal autonomic headaches. This review summarizes drug therapy of cluster attacks and prophylactic treatment. Neurostimulation methods are not addressed. The therapy for acute cluster attacks includes inhalation of 100% oxygen, subcutaneous administration of sumatriptan, and intranasal application of sumatriptan or zolmitriptan. Bridging therapy, which is used until oral prophylactic therapy is effective, is performed either with oral prednisolone or with a pharmacological block of the major occipital nerves. Best documented drugs for preventive treatment of cluster headache are verapamil and lithium, and possibly effective drugs are gabapentin, topiramate, divalproex sodium, and melatonin. The efficacy of monoclonal antibodies to the calcitonin gene-related peptide so far has been only demonstrated for episodic cluster headache. Several drug therapies are being investigated including ketamine, onabotulinumtoxinA, lysergic acid, and sodium oxybate. Springer International Publishing 2021-12-17 2022 /pmc/articles/PMC8748342/ /pubmed/34919214 http://dx.doi.org/10.1007/s40265-021-01658-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review Article
Diener, Hans Christoph
May, Arne
Drug Treatment of Cluster Headache
title Drug Treatment of Cluster Headache
title_full Drug Treatment of Cluster Headache
title_fullStr Drug Treatment of Cluster Headache
title_full_unstemmed Drug Treatment of Cluster Headache
title_short Drug Treatment of Cluster Headache
title_sort drug treatment of cluster headache
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748342/
https://www.ncbi.nlm.nih.gov/pubmed/34919214
http://dx.doi.org/10.1007/s40265-021-01658-z
work_keys_str_mv AT dienerhanschristoph drugtreatmentofclusterheadache
AT mayarne drugtreatmentofclusterheadache